Prescription drug · ANDA
Constulose (Lactulose) NDC 45963-439
Lactulose 10 g/15mL · Solution · Oral · Actavis Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 45963-439-63 | 4596304396345963043963 | 237 mL in 1 BOTTLE (45963-439-63)Marketed from Feb 28, 2011 | |
| 45963-439-65 | 4596304396545963043965 | 946 mL in 1 BOTTLE (45963-439-65)Marketed from Feb 28, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Constulose
- Generic name (nonproprietary)
- lactulose
- Active ingredients
- Lactulose — 10 g/15mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Actavis Pharma, Inc.NDC labeler code 45963
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090503
- Marketing start
- Listing expires
- Other FDA classes
- Acidifying Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 45963-439_7fd63ff0-fccd-408a-9c56-2c2fefdb74fcSPL ID 7fd63ff0-fccd-408a-9c56-2c2fefdb74fcSPL set ID 461ec39f-eeb4-4460-9b5c-62367d47162bRxCUI 391937, 544452UNII 9U7D5QH5AE
- Pharmacologic class
- Osmotic Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N445963043963followed by a unit qualifier and the quantityPackage 45963-0439-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
Excerpt only. Read the full label for complete information.
About NDC 45963-439
- What is NDC 45963-439?
- 45963-439 is the product NDC for Constulose (lactulose), Lactulose 10 g/15mL solution, listed with the FDA by Actavis Pharma, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Constulose (Lactulose).
- What is the active ingredient?
- Lactulose.
- Who is the labeler?
- Actavis Pharma, Inc., NDC labeler code 45963. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Constulose?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 090503
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lactulose | Lactulose 10 g/15mL | SolutionOral | American Health Packaging | 60687-917 |